Sun Pharma receives USFDA approval for ophthalmology product

The USFDA has granted an approval for Sun Pharma to start selling the generic version of Acular, ketorolac tromethamine ophthalmic solution, 0.5%.

Ketorolac tromethamine ophthalmic solution is prescribed to provide temporary relief of ocular itching due to seasonal allergic conjunctivitis, and also in treating post-operative inflammation in patients who have undergone cataract extraction.

Acular, a licensed medication of US-based Allergan, has annual sales of $40 million a year in the US.

Comments are closed.